Date:2/3/2010

g of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including Nordic Medcom AB's ability to successfully promote, sell and service our products, customer demand for our products in the UK , Ireland, Sweden, Denmark and Finland,  and factors that are discussed in NxStage's Quarterly Report on Form 10-Q for the period ended September 30, 2009 filed with the SEC. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

    
    
    NxStage Medical: 
    Kristen K. Sheppard, Esq.
    VP, Investor Relations
    ksheppard@nxstage.com

SOURCE NxStage Medical, Inc.

RELATED LINKS
http://www.nxstage.com

'/>"/>

SOURCE NxStage Medical, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)
2. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
3. NxStage(R) Reports Significant Interim FREEDOM Study Results
4. NxStage(R) to Report Third Quarter 2009 Financial Results
5. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
6. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
7. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
8. Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
9. Bavarian Nordic Enters Clinical Trials with HIV Multiantigen Vaccine
10. ETEX Corporation Announces Distribution Agreement With OrthoPediatrics Corp.
11. Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments